Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

A Systems medicine approach to chronic inflammatory disease (SYSCID)

Start date: Jan 1, 2017, End date: Mar 31, 2022,

"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease, systemic lupus erythematodes and rheumatoid arthritis. We have joined 15 partners from major cohorts and initiatives in Europe (e.g.IHEC, ICGC, Twins ...
Read Project

 16

 FINISHED 

Brain-Specific, Modular and Active RNA Therapeutics (B-SMART)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

The overall objective of B-SMART is: 1. to design modular nanoparticles, 2. to manufacture them via a quality-by-design protocol, 3. to achieve delivery of therapeutic RNAs to the brain and treat neurodegenerative diseases. I. To design modular nanoparticles consisting of o an active RNA payloado established (lipid-based), emerging (trigger-responsive polymer-based) or exploratory (extracellular v ...
Read Project

 9

 FINISHED 
G2P-SOL is a research alliance bringing together the major European and International repositories of germplasm with public and private institutions active in genomics, phenotyping and breeding in the four major Solanaceous crops: potato, tomato, pepper and eggplant. These four crops constitute 66% of the value of European horticultural production, and over 65,000 accessions are available within t ...
Read Project

 20

 FINISHED 
The world demographic growth and global climate change are major challenges for human society,hence the need to design new strategies for maintaining high crop yield in unprecedented environmental conditions.The objective of TomGEM is to design new strategies aiming to maintain high yields of fruit and vegetables at harsh temperature conditions, using tomato as a reference fleshy fruit crop.As yie ...
Read Project

 18

 FINISHED 
... The project is based on an integrative multi-actor approach, from cultivation techniques to molecular studies, aiming the development and validation of a range of tools to improve competitiveness of European berry production, and eventually the attraction and confidence of consumers. The selection of the model species can be considered as strategic since strawberry is the most important berry cro ...
Read Project

 19

 FINISHED 

Chimeric Antigen Receptors (CARs) for Advanced Therapies (CARAT)

Start date: Jan 1, 2016, End date: Dec 31, 2019,

Chimeric antigen receptors (CARs) are artificial surface receptors that can be introduced into somatic cells by genetic engineering and that act as recognition molecules like antibodies or T-cell receptors. In this respect, CARs are increasingly used for cellular therapy to redirect T-cells specifically towards killing of cancer cells. Recent success stories of cancer therapy with CAR modified T-c ...
Read Project

 9

 FINISHED 
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they compromise a diverse family of rare genetic diseases typically caused by single gene defects that often provoke significant morbi ...
Read Project

 8

 FINISHED 

Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD)

Start date: Dec 1, 2015, End date: Nov 30, 2019,

The overall objective of this project is to identify novel drug candidates capable of slowing down the progression of neurodegeneration in the subset of Parkinson’s disease (PD) patients with overt mitochondrial dysfunction. Multi-modal phenotypic characterisation of cohorts of monogenic PD patients with overt mitochondrial dysfunction will be used as an anchor for the discovery of two extreme coh ...
Read Project

 8

 FINISHED 

The European IPR Helpdesk (European IPR Helpdesk)

Start date: Jan 1, 2015, End date: Dec 31, 2018,

"The European IPR Helpdesk, funded under the Horizon 2020 programme, supports at an EU level cross-border SME and research activities to: manage, diffuse and valorise technologies and other Intellectual Property (IP) Rights and IP Assets. It provides support products and services, including: support to candidates and participants in programmes such as Horizon 2020 and COSME on their IP needs, fre ...
Read Project

 4

 FINISHED 
...oMMiTMent will ensure an effective therapy with diminished undesirable adverse effects, largely replacing splenectomy.CoMMiTMenT includes clinical partners and builds a strong relationship with the European Network for Rare and Congenital Anaemias (ENERCA). Furthermore, CoMMiTMenT acts as a bridge between the technology-driven SMEs and ENERCA and, as such, supports the competitiveness of Europe in ...
Read Project

 9

 FINISHED 
The rise of the system complexity, the rapid changing of consumers demand require the European industry to produce more customized products with a better use of resources.The main objective of IMPROVE is to create a virtual Factory of the Future, which provides services for user support, especially on optimization and monitoring. By monitoring anomalous behaviour will be detected before it leads t ...
Read Project

 13

 FINISHED 
...matic data about young people’s mobility patterns in Europe based on qualitative case studies, a mobility survey and on secondary data analysis;[3] provide a quantitative integrated database on European youth mobility;[4] offer a data based theoretical framework in which mobility can be reflected, thus contributing to the scientific and political debates.[5] explore factors that foster and factors ...
Read Project

 9

 FINISHED 
Tomato is the second most consumed vegetable in the EU and a major dietary source of many nutrients, vitamins and antioxidants. Consumers complaints about the loss of flavour in modern tomatoes, provide an opportunity for the valorisation of traditional tomato varieties, in order to protect them from genetic erosion and the replacement by higher-yielding, pest resistant modern cultivars. Genetic, ...
Read Project

 16

 FINISHED 
...gary, Italy, Spain, Switzerland, Turkey, and the United Kingdom). These ten countries represent the main empirical scope of the project, but whenever possible, the analysis is extended to include all European countries. CUPESSE has five main objectives. The first objective is to obtain a more refined understanding of the supply side of young adults’ employment by concentrating on how the inter-gen ...
Read Project

 14

 FINISHED 
The main objective of PneumoNP is the development of a theragnostic system for the treatment of lung Gram-negative bacterial infections. As a proof of concept PneumoNP will focus the attention on Klebsiella pneumoniae caused infections. A diagnostic kit will be developed to enable a rapid and precise identification of the bacteria strain causing the infection and avoid the use of wide spectrum a ...
Read Project

 11

 FINISHED 

Synthetic Cellular Signaling Circuits (SynSignal)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

... generation of flavours, fragrances, and nutritional ingredients. Our innovations will provide immediate benefits to the health and well-being of Europe’s citizens and to the competitiveness of key European industries alike, and catalyze their transition towards sustainable production principles. In addition, all partners in SynSignal themselves will draw great benefit from the activities proposed ...
Read Project

 10

 FINISHED 
"Plant natural products have been utilised by human civilisation for millennia, providing vital medicines and essential dietary components. More recently bioactive compounds from plant sources have been used in cosmetics, as health supplements and are important components of feedstuffs. Despite significant investments new activities and new sustainable biosources are required to alleviate our reli ...
Read Project

 15

 FINISHED 
Fit for Health 2.0 aims to promote and enhance a sustainable participation of European industry in the Health-related sector of Horizon 2020 (H2020). Focusing on research-intensive, high technology SMEs the project offers targeted support measures, covering the entire innovation cycle of research projects. Key assets are highly qualified advice and support including a mentoring and coaching approa ...
Read Project

 11

 FINISHED 
Neuro-immune alterations in the peripheral and central nervous system play a role in the pathophysiology of chronic pain, and non-coding RNAs (ncRNAs) regulate both immune and neuronal processes. Therefore, ncRNAPain proposes that ncRNAs are critically important master switches for chronic pain.ncRNAPain represents a multidisciplinary consortium of clinical partners, molecular and systems-level n ...
Read Project

 12

 FINISHED 
Developing robust, reproducible, interoperable and collaborative hyper-models of diseases and normal physiology is a sine qua non necessity if rational, coherent and comprehensive exploitation of the invaluable information hidden within human multiscale biological data is envisaged. Responding to this imperative in the context of both the broad Virtual Physiological Human (VPH) initiative and the ...
Read Project

 17

 FINISHED 
SENSIndoor aims at the development of novel nanotechnology based intelligent sensor systems for selective monitoring of Volatile Organic Compounds (VOC) for demand controlled ventilation in indoor environments. Greatly reduced energy consumption without adverse health effects caused by the Sick Building Syndrome requires optimized ventilation schemes adapted to specific application scenarios like ...
Read Project

 10

 FINISHED 

Innovation Management Support for SMEs (Innosupport)

Start date: Jan 1, 2015, End date: Dec 31, 2016,

The general objective of the described actions is to contribute to smart growth in the European Union by increasing the efficiency and effectiveness of investments in research, development and innovation and by contributing to a better and more efficient connection of actors along the innovation chain.To achieve the above mentioned objectives the proposed grant shall:a) Identify bottlenecks to the ...
Read Project

 4

 FINISHED 
Goals: We will carry out a regenerative medicine clinical trial of the therapeutic system OSTEOGROW for regenerating bone through harnessing a novel bone regenerative product to accelerate and enhance bone repair.The osteogenic regenerative product is composed of an autologous carrier and a biologically active recombinant human protein offering a therapeutic solution in bone regeneration superior ...
Read Project

 11

 FINISHED 

A BLUEPRINT of Haematopoietic Epigenomes (BLUEPRINT)

Start date: Oct 1, 2011, End date: Sep 30, 2016,

In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease. BLUEPRINT will focus on distinct types of haematopoietic cells from healthy individuals and o ...
Read Project

 45

 FINISHED 
The overall strategic objective of MultiBioPro is to exploit natural resources from genetic varieties of two industry-utilized plant species, poplar and the tobacco tree Nicotiana glauca, for direct applicability to novel industrial end products. The consortium will explore already existing poplar and N. glauca genotypes in parallel with innovative state-of-the-art translational research from the ...
Read Project

 12

 FINISHED 
...ject is the transition of NGS from a basic research tool to a highly efficient technology for pathogen typing and diagnostics on the EU level. This objective will be achieved by establishing a unique European consortium that brings together three SMEs leading in the fields of ""data to knowledge"" and ""NGS genome research"" with leading experts in clinical microbiology of three model pathogens of ...
Read Project

 8

 FINISHED 
"NOTOX will develop and establish a spectrum of systems biological tools including experimental and computational methods for i) organotypic human cell cultures suitable for long term toxicity testing and ii) the identification and analysis of pathways of toxicological relevance. NOTOX will initially use available human HepaRG and primary liver cells as well as mouse small intestine cultures in 3D ...
Read Project

 13

 FINISHED 
ComplexINC conceptualizes and systematically generates advanced tool-kits to enable high-throughput assembly of complex biologics and metabolic pathways in eukaryotic expression systems, for micro- to large scale production of high-quality protein specimens for drug discovery and as bio-therapeutics. Essential parts of these tool-kits will be innovative next-generation HT DNA assembly pipelines fo ...
Read Project

 8

 FINISHED 

Economic iNsTRuments to Achieve Climate Targets in Europe (ENTRACTE)

Start date: Sep 1, 2012, End date: Sep 30, 2015,

The ENTRACTE research project assesses the EU’s climate policy portfolio. While the EU ETS is key to promote the transition towards a low-carbon economy, ambitious GHG emissions reductions will be reached only if this scheme is improved and supported by complementary policies. A carefully considered policy design has to take into account existing market failures other than the climate externality, ...
Read Project

 9

 FINISHED 
Medicine is undergoing a revolution that is transforming the nature of healthcare from reactive to preventive. The changes are catalyzed by a new systems approach to disease which focuses on integrated diagnosis, treatment and prevention of disease in individuals. This will replace our current mode of medicine over the coming years with a personalized predictive treatment . While the goal is clea ...
Read Project

 19

 FINISHED 
The SAM.SSA project aims at developing new phase change materials (PCM) for thermal energy seasonal storage applications (STES) in the range of medium temperatures. The generated materials shall provide:• Low cost, environmentally sound and safe solutions for seasonal storage applications• Easy adjustment of the melting point for optimal ”tuning” to the required applications• Energy densities > 20 ...
Read Project

 9

 FINISHED 
Major objective: It is our aim to develop a lipid based diet that is able to delay or prevent onset of Alzheimer’s disease and related diseases and has a stabilizing effect on cognitive performance in aging. Multiple lines of evidence suggest that there is a large overlap between risk factor of these three diseases. Importantly, there is equally strong evidence that prevention and treatment of the ...
Read Project

 19

 FINISHED 

Innovation Management Support for SMEs (Innosupport)

Start date: Jul 1, 2014, End date: Dec 31, 2014,

The general objective of the described actions is to contribute to smart growth in the European Union by increasing the efficiency and effectiveness of investments in research, development and innovation and by contributing to a better and more efficient connection of actors along the innovation chain.To achieve the above mentioned objectives the proposed grant shall: a) Identify bottlenecks to th ...
Read Project

 2

 FINISHED 
... for improving flight safety. The project will contribute in this sense to: 1) the minimization of the factors that lead to pilot loss of control resulting in increased enhancement of the European aircraft safety and 2) will strengthen the European Aeronautics Industry competitiveness in their time- and cost-effective design tools."
Read Project

 10

 FINISHED 
...otential. These shall contribute to regional development, while taking advantage of the knowledge and experience existing in other regions of Europe. Hence RAMSES will help to fully realize the European Research Area."
Read Project

 4

 FINISHED 
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, is a neglected bacterial infection of the poor in remote rural areas, mostly affecting children. BUD, the third most common mycobacterial disease in immunocompetent humans after tuberculosis and leprosy, is most endemic in West Africa, but cases have been reported from more than 30 countries. BUD is a mutilating disease leading to sever ...
Read Project

 16

 FINISHED 
"The majority of compounds used to treat diseases come from a single group of organisms, the actinomycetes. This over-reliance on a single organism to produce the worlds drugs is a major problem for the development of compounds with alternative modes of action which can overcome and delay the onset of drug resistance. To address this problem we will form an international multi-disciplinary group o ...
Read Project

 6

 FINISHED 
...terogeneity reflect distinct functions? How do astroglial and neuronal networks interact locally and temporally? How does disruption of neuron-glia interactions contribute to brain disorders? Leading European research groups in the field have gathered in NeuroGLIA to address such questions using a multi-disciplinary approach, including transgenic astroglia-subtype specific mice, electrophysiology ...
Read Project

 8

 FINISHED 
Background Tuberculosis and HIV/AIDS are on the rise worldwide, representing a global public health problem with considerable mutual interaction: TB is the leading cause of mortality for people living with HIV/AIDS, and HIV is the most potent force driving the TB epidemic in countries with a high prevalence of HIV . Especially in rural areas of Africa, Latin America, India and Russia both diseases ...
Read Project

 14

 FINISHED 
To meet growing demand for high-level professional translation, especially in candidate countries, the Master in Translation project will develop and test the first European master programme in translation, collaborating with social partners in the industry. The project further expects to serve as an example of good practice in developing a European joint degree. Alongside the creation of a traini ...
Read Project

 20